S
ZBIO

SignatureFD’s Zenas BioPharma ZBIO Stock Holding History

SignatureFD’s Portfolio ZBIO Stock Details ZBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.8K Buy
1,134
+764
+206% +$15.2K ﹤0.01% 2172
2026
Q1 		$7.23K Sell
370
-19
-5% -$426 ﹤0.01% 2647
2025
Q4 		$14.1K Buy
389
+57
+17% +$1.88K ﹤0.01% 2266
2025
Q3 		$7.37K Buy
332
+37
+13% +$602 ﹤0.01% 2515
2025
Q2 		$2.86K Buy
295
+167
+130% +$1.63K ﹤0.01% 2774
2025
Q1 		$1.01K Buy
+128
New +$1K ﹤0.01% 3029

Other funds holding ZBIO

IGAM
iA Global Asset Management Quebec, Quebec, Canada $8.42B AUM 47.61% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return

SignatureFD's ZBIO Position: Q2 2026 in Review

SignatureFD increased its Zenas BioPharma (ZBIO) stake by 206% in Q2 2026, buying an estimated $15.2K and bringing the position to 1,134 shares worth $28.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2172.

SignatureFD first reported a position in ZBIO in Q1 2025 and has held it in 6 quarters since. 17 funds tracked by Wall St. Rank hold ZBIO as of Q2 2026.

  • SignatureFD held 1,134 shares of Zenas BioPharma worth $28.8K as of Q2 2026.
  • SignatureFD bought 764 Zenas BioPharma shares in Q2 2026, an estimated $15.2K.
  • Zenas BioPharma made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #2172 holding.
  • SignatureFD first reported a position in Zenas BioPharma in Q1 2025 and has held it in 6 quarters since.
  • 17 funds tracked by Wall St. Rank held Zenas BioPharma as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.